Keyphrases
A1 Receptor
6%
Acute Effects
6%
Ca(II)
20%
Endothelial Cells
13%
Endothelial Nitric Oxide Synthase (eNOS)
13%
Endothelium-dependent
6%
ERK2
6%
Fura-2
6%
Glucagon-like
100%
Human Endothelial Cells
100%
L-NAME
6%
Maximal Voluntary Contraction
6%
Nitric Oxide Synthase Inhibitors
6%
NO Synthesis
6%
PCR Analysis
6%
Phosphorylation
20%
Rat Mesenteric Artery
100%
Resistance Arteries
6%
Thromboxane
6%
U46619
6%
Vascular Endothelial Growth Factor
100%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
6%
Vasodilation
13%
Vessel Tone
6%
Wistar Rats
6%
Medicine and Dentistry
Arginine Methyl Ester
9%
Artery Resistance
27%
Blood Vessel Permeability
9%
Endothelial Cell
100%
Endothelial Nitric Oxide Synthase
9%
Fura-2
9%
Glucagon Like Peptide 1
100%
Glucagon Like Peptide 1 Receptor
9%
Mesenteric Artery
100%
Messenger RNA
9%
Mitogen Activated Protein Kinase 3
9%
Nitric Oxide Synthase Inhibitor
9%
Reverse Transcription Polymerase Chain Reaction
9%
Thromboxane
9%
Vasculotropin A
100%
Vasodilatation
18%
Pharmacology, Toxicology and Pharmaceutical Science
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
9%
Arginine Methyl Ester
9%
Endothelial Nitric Oxide Synthase
9%
Fura-2
9%
Glucagon-Like Peptide 1 Receptor
9%
Glucagon-Like Peptide-1
100%
Messenger RNA
9%
Mitogen Activated Protein Kinase 3
9%
Nitric Oxide Synthase Inhibitor
9%
Thromboxane
9%
Vasculotropin A
100%
Wistar Rat
9%